The Bipolar, Schizophrenia and Psychosis Research Initiative (B-Sprint) study from the Brain and Genomics Hub aims to go beyond diagnostic boundaries, to help identify ways to develop more targeted treatment approaches for people living with these conditions, and to improve how they are diagnosed.
Taking part
To help researchers learn more about psychosis, schizophrenia, bipolar disorder, and schizoaffective disorder, we are helping to recruit 600 people with lived experience of these conditions.
Once the team have confirmed you are eligible to take part, you will:
- be asked questions about your mental health and life experiences
- complete some cognitive tasks to assess your memory and learning styles
- be asked for a blood sample
- have a MEG and MRI scan
If this sounds of interest, register your details today so our researchers can get in touch and discuss your eligibility to take part.
Please note that, depending on when you register, it may take a month or two for them to get in touch.
The Brain and Genomics Hub
The Brain and Genomics Hub is one of six new research hubs that make up the Mental Health Research Platform funded by UKRI. The platform was established to accelerate progress towards new and more effective treatments for serious mental illness.
The Hub is made up of a number of universities and third sector organisations working together to better understand serious mental illnesses and to better support the people living with these conditions. The third sector organisations Adferiad and Bipolar UK are helping the Hub to put the lived experiences of people at the heart of its research.